The findings of our study demonstrated that, although routinely used biomarkers such as serum CRP and synovial WBC remain valuable in diagnosing septic arthritis, incorporating novel biomarkers, such as PTX3, IL-6, and presepsin, could enhance diagnostic accuracy. The gene discussed is IL6; the disease is bacterial arthritis.